<i>TFAP2E–DKK4</i> and Chemoresistance in Colorectal Cancer
Matthias Ebert(University of Mannheim), Roland M. Schmid(Technical University of Munich), Tibor Schuster(Technical University of Munich), Christoph Röcken(Christian-Albrechts-Universität zu Kiel), Karsten Schulmann(Klinikum Arnsberg), Philipp Ströbel(Universitätsmedizin Göttingen), Anke Reinacher‐Schick(Ruhr University Bochum), Rainer Porschen(Klinikum Bremen-Mitte), David J. Hughes(Centre international de recherche sur le cancer), Ralf‐Dieter Hofheinz(Goethe University Frankfurt), Jan Stöhlmacher-Williams(Technische Universität Dresden), Elke Burgermeister(Heidelberg University), Andrea Tannapfel(Leipzig University), Marc Tänzer(Heidelberg University), Robert Rosenberg(Harvard University), Reimo Tetzner(Epigenomics (Germany)), Gisela Keller(Technical University of Munich), Rupert Langer(University of Bern), Katja Specht(Heidelberg University), Catherine Lofton–Day(Seattle University), A. Kretzschmar(University Hospital Leipzig), Benjamin Balluff(Maastricht University)
Cited by 184
Related Papers
Maintenance Olaparib for Germline <i>BRCA</i> -Mutated Metastatic Pancreatic Cancer
|New England Journal of Medicine|2019|2.2k
Vemurafenib in Multiple Nonmelanoma Cancers with <i>BRAF</i> V600 Mutations
|New England Journal of Medicine|2015|1.7k